ICD-10-CM Billable Code

M60.14

Interstitial myositis, hand

Clinical Classification Guidelines

Medical Intelligence & Overview

Interstitial myositis of the hand is a rare inflammatory condition affecting the muscles within the hand. It involves inflammation and degeneration of muscle tissue, which can lead to pain, weakness, and impaired hand function. Although not widely common, this condition can significantly impact daily activities and quality of life. Recognizing the symptoms and understanding possible causes can aid in early diagnosis and management.

Causes & Symptoms

Clinical Causes: Autoimmune reactions where the body's immune system mistakenly attacks its own muscle tissue. Infections, including bacterial, viral, or parasitic agents that trigger muscle inflammation. Exposure to certain toxins or chemicals that may cause muscle damage. Chronic physical stress or overuse of the hand muscles, leading to inflammation. Genetic predisposition that may influence susceptibility to muscle inflammatory conditions. Underlying medical conditions such as other autoimmune or inflammatory diseases.

Key Symptoms: Localized muscle pain in the hand that worsens with activity or movement. Swelling and tenderness in the affected muscles. Weakness in hand muscles, leading to reduced grip strength. Difficulty performing fine motor tasks, such as buttoning or writing. Muscle stiffness, especially after periods of rest. Occasional warmth or redness over the affected area. Potential fatigue in the hand muscles after sustained use.

Diagnostic & Treatment

Diagnosis Path: Medical history assessment focusing on symptom duration, activity levels, and medical background. Physical examination to evaluate muscle strength, tenderness, and swelling. Blood tests detecting markers of inflammation, such as elevated C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR). Electromyography (EMG) to assess electrical activity in muscles and distinguish myositis from other conditions. Muscle imaging studies, including magnetic resonance imaging (MRI), to identify inflammation and muscle tissue changes. Muscle biopsy may be performed to confirm diagnosis by examining muscle tissue microscopically for inflammation and degeneration.

Treatment Protocols: Anti-inflammatory medications such as corticosteroids to reduce inflammation and relieve symptoms. Immunosuppressive drugs in cases where autoimmune processes are identified. Physical therapy aimed at maintaining muscle strength and flexibility without exacerbating symptoms. Rest and activity modification to prevent worsening of inflammation. Pain management strategies, including analgesics if necessary. Monitoring and managing any underlying medical conditions that may contribute to myositis. In rare cases, specialized treatments like intravenous immunoglobulin (IVIG) may be considered.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M60.14 a billable ICD-10 code?
Yes, M60.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M60.14?
Clinical documentation must specify the nature of Interstitial myositis, hand and any associated comorbidities for accurate reporting.

Cite this Clinical Reference